Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Tusell

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Transfusion|May 1, 1993
Continuous infusion of factor VIII concentrate to a patient with severe von Willebrand diseaseJ B Montoro, C Altisent, A Pineda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2002
Results of an orthopaedic survey in young patients with severe haemophilia in SpainJ M Tusell, J A Aznar, F Querol, et al.
Neuroscience Letters|July 19, 1996
Reserpine potentiates NMDA-induced c-fos mRNA expression in the mouse brainS Ferré, J M Tusell, S Barrón, et al.
Anales Espanoles De Pediatria|December 1, 1992
[Retinitis in a hemophiliac boy with acquired immunodeficiency syndrome]F Munell Casadesus, J M Tusell Puigbert, J Gibernau, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|March 31, 2004
Inhibition of beta-amyloid toxicity by short peptides containing N-methyl amino acidsM Cruz, J M Tusell, D Grillo-Bosch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Efficacy of high-temperature dry heat in inactivating parvovirusD B Rubinstein, G Flores, J C Juarez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting-factor concentrates considered safe against human immunodeficiency and hepatitis C virusesG Flores, J C Juárez, J B Montoro, et al.
Medicina Clinica|March 16, 1991
[The administration of factor VIII concentrates to hemophiliacs by continuous perfusion pump]S Rodríguez Bueno, J B Montoro Ronsano, B Martínez Sánchez, et al.
Blood|September 15, 1995
An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patientsJ B Montoro, J Oliveras, J I Lorenzo, et al.
Anales Espanoles De Pediatria|September 22, 2000
[Thrombophilia and Perthes' disease?]J M Tusell Puigbert, C Aulesa Martínez, M Aguirre Canyadell, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Transfusion|May 1, 1993
Continuous infusion of factor VIII concentrate to a patient with severe von Willebrand diseaseJ B Montoro, C Altisent, A Pineda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2002
Results of an orthopaedic survey in young patients with severe haemophilia in SpainJ M Tusell, J A Aznar, F Querol, et al.
Neuroscience Letters|July 19, 1996
Reserpine potentiates NMDA-induced c-fos mRNA expression in the mouse brainS Ferré, J M Tusell, S Barrón, et al.
Anales Espanoles De Pediatria|December 1, 1992
[Retinitis in a hemophiliac boy with acquired immunodeficiency syndrome]F Munell Casadesus, J M Tusell Puigbert, J Gibernau, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|March 31, 2004
Inhibition of beta-amyloid toxicity by short peptides containing N-methyl amino acidsM Cruz, J M Tusell, D Grillo-Bosch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Efficacy of high-temperature dry heat in inactivating parvovirusD B Rubinstein, G Flores, J C Juarez, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting-factor concentrates considered safe against human immunodeficiency and hepatitis C virusesG Flores, J C Juárez, J B Montoro, et al.
Medicina Clinica|March 16, 1991
[The administration of factor VIII concentrates to hemophiliacs by continuous perfusion pump]S Rodríguez Bueno, J B Montoro Ronsano, B Martínez Sánchez, et al.
Blood|September 15, 1995
An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patientsJ B Montoro, J Oliveras, J I Lorenzo, et al.
Anales Espanoles De Pediatria|September 22, 2000
[Thrombophilia and Perthes' disease?]J M Tusell Puigbert, C Aulesa Martínez, M Aguirre Canyadell, et al.
Pageof 7